Protagonist Therapeutics, Inc.
PTGX
$58.36
$2.173.86%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.15% | 78.02% | 22.63% | 46.13% | 79.96% |
Total Receivables | 1,941.68% | -90.98% | 1,530.76% | 4,006.15% | 2,640.00% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -26.41% | -2.28% | 16.81% | 32.32% | 59.26% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 5.54% | -3.46% | 66.39% | 46.75% | 80.14% |
|
|||||
Total Current Assets | 5.54% | -3.46% | 66.39% | 46.75% | 80.14% |
Net Property, Plant & Equipment | 5.53% | 736.45% | 486.64% | 320.62% | 264.61% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 28.89% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Assets | 16.82% | 17.93% | 108.05% | 82.98% | 91.79% |
|
|||||
Total Accounts Payable | -10.47% | -16.82% | 109.20% | 143.53% | -20.64% |
Total Accrued Expenses | 1.16% | -29.09% | 22.64% | -16.40% | -21.56% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | 239.39% | -55.30% | -97.50% | -- |
Total Finance Division Other Current Liabilities | -35.13% | -2.71% | 21,129.41% | 14,093.20% | 12,977.71% |
Total Other Current Liabilities | -35.13% | -2.71% | 21,129.41% | 14,093.20% | 12,977.71% |
Total Current Liabilities | -14.60% | -12.02% | 122.80% | 59.97% | 57.50% |
|
|||||
Total Current Liabilities | -14.60% | -12.02% | 122.80% | 59.97% | 57.50% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -17.00% | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -74.10% | -71.73% | -- | -- | -- |
Total Liabilities | -31.81% | -22.88% | 226.36% | 158.16% | 177.69% |
|
|||||
Common Stock & APIC | 7.59% | 7.44% | 6.66% | 6.07% | 8.56% |
Retained Earnings | 11.85% | 13.76% | 44.69% | 26.57% | 27.91% |
Treasury Stock & Other | 93.98% | 137.12% | 21.90% | 885.88% | -25.76% |
Total Common Equity | 23.40% | 22.95% | 100.58% | 76.04% | 84.08% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 23.40% | 22.95% | 100.58% | 76.04% | 84.08% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 23.40% | 22.95% | 100.58% | 76.04% | 84.08% |
|